Table 1 Characteristics of the Study Subjects
Non-cancer | Cancer | p-value | |
|---|---|---|---|
N = 8784 | N = 2196 | ||
Age | 71.09 ± 7.19 | 71.4 ± 7.09 | 0.0739 |
Age Group | 0.9160 | ||
20–39 | 9 (0.10) | 2 (0.09) | |
40–59 | 593 (6.75) | 140 (6.38) | |
60–79 | 7339 (83.55) | 1847 (84.11) | |
> =80 | 843 (9.60) | 207 (9.43) | |
Gender | 1.0000 | ||
Female | 6100 (69.44) | 1525 (69.44) | |
Male | 2684 (30.56) | 671 (30.56) | |
CCI | 0.8847 | ||
0 | 1457 (16.59) | 355 (16.17) | |
1 | 2158 (24.57) | 556 (25.32) | |
2 | 2105 (23.96) | 520 (23.68) | |
2+ | 3064 (34.88) | 765 (34.84) | |
Comorbidities | |||
Myocardial infarct | 198 (2.25) | 59 (2.69) | 0.2304 |
congestive heart failure | 980 (11.16) | 254 (11.57) | 0.5865 |
peripheral vascular | 294 (3.35) | 73 (3.32) | 0.9577 |
cerebrovascular disease | 1796 (20.45) | 458 (20.86) | 0.6706 |
dementia | 231 (2.63) | 63 (2.87) | 0.5348 |
chronic lung disease | 3497 (39.81) | 869 (39.57) | 0.8378 |
connective tissue disease | 658 (7.49) | 149 (6.79) | 0.2569 |
Ulcer | 4583 (52.17) | 1134 (51.64) | 0.6535 |
chronic liver disease | 1407 (16.02) | 339 (15.44) | 0.5058 |
Diabetes | 2455 (27.95) | 617 (28.1) | 0.8901 |
diabetes with end organ damage | 367 (4.18) | 102 (4.64) | 0.3333 |
Hemiplegia | 92 (1.05) | 22 (1) | 0.8506 |
moderate or severe kidney disease | 642 (7.31) | 178 (8.11) | 0.2039 |
Moderate or severe liver disease | – | – | |
AIDS | – | – | |
Infection | 164 (1.87) | 38 (1.73) | 0.6700 |
1-year Mortality | 146 (1.66) | 90 (4.10) | <.0001 |
Chemotherapy | 0 (0.00) | 708 (32.24) | |
Metastasis | 0 (0.00) | 7 (0.32) | |